Prokineticin Receptor 1 Antagonist PC-10 as a Biomarker for Imaging Inflammatory Pain
- 18 March 2011
- journal article
- Published by Society of Nuclear Medicine in Journal of Nuclear Medicine
- Vol. 52 (4) , 600-607
Abstract
Prokineticin receptor 1 (PKR1) and its ligand Bv8 were shown to be expressed in inflammation-induced pain and by tumor-supporting fibroblasts. Blocking this receptor might prove useful for reducing pain and for cancer therapy. However, there is no method to quantify the levels of these receptors in vivo. Methods: A nonpeptidic PKR1 antagonist, N-{2-[5-(4-fluoro-benzyl)-1-(4-methoxy-benzyl)-4,6-dioxo-1,4,5,6-tetrahydro-[1,3,5]triazin-2-ylamino]-ethyl}-guanidine, which contains a free guanidine group, was labeled with 18F by reacting the guanidine function with N-succinimidyl-4-18F-fluorobenzoate to give the guanidinyl amide N-(4-18F-fluoro-benzoyl)-N′-{2-[5-(4-fluoro-benzyl)-1-(4-methoxy-benzyl)-4,6-dioxo-1,4,5,6-tetrahydro-[1,3,5]triazin-2-ylamino]-ethyl}-guanidine (18F-PC-10). Inflammation was induced in C57BL/6 mice by subcutaneous injection of complete Freund adjuvant in the paw. The mice were imaged with 18F-PC-10, 18F-FDG, and 64Cu-pyruvaldehyde bis(4-methyl-3-thiosemicarbazone) (64Cu-PTSM) at 24 h after complete Freund adjuvant injection using a small-animal PET device. Results: 18F-PC-10 was synthesized with a radiochemical yield of 16% ± 3% (decay-corrected). 18F-PC-10 accumulated specifically in the inflamed paw 4- to 5-fold more than in the control paw. Compared with 18F-PC-10, 18F-FDG and 64Cu-PTSM displayed higher accumulation in the inflamed paw but also had higher accumulation in the control paw, demonstrating a reduced signal-to-background ratio. 18F-PC-10 also accumulated in PKR1-expressing organs, such as the salivary gland and gastrointestinal tract. Conclusion: 18F-PC-10 can be used to image PKR1, a biomarker of the inflammation process. However, the high uptake of 18F-PC-10 in the gastrointestinal tract, due to specific uptake and the metabolic processing of this highly lipophilic molecule, would restrict its utility.Keywords
This publication has 34 references indexed in Scilit:
- Neuroinflammation in inflammatory bowel diseaseJournal of Neuroinflammation, 2010
- Bv8/Prokineticin proteins and their receptorsLife Sciences, 2007
- Modulators of Pain: Bv8 and ProkineticinsCurrent Neuropharmacology, 2006
- Bv8, the amphibian homologue of the mammalian prokineticins, induces a proinflammatory phenotype of mouse macrophagesBritish Journal of Pharmacology, 2006
- Radioiodinated phenylalanine derivatives to image pancreatic cancer: a comparative study with [18F]fluoro-2-deoxy-d-glucose in human pancreatic carcinoma xenografts and in inflammation modelsNuclear Medicine and Biology, 2005
- Structural Determinants Required for the Bioactivities of Prokineticins and Identification of Prokineticin Receptor AntagonistsMolecular Pharmacology, 2004
- 18F-labeled RGD peptide: initial evaluation for imaging brain tumor angiogenesisNuclear Medicine and Biology, 2004
- Isolation and identification of EG-VEGF/prokineticins as cognate ligands for two orphan G-protein-coupled receptorsBiochemical and Biophysical Research Communications, 2002
- MIT1, a black mamba toxin with a new and highly potent activity on intestinal contractionFEBS Letters, 1999
- Bv8, a small protein from frog skin and its homologue from snake venom induce hyperalgesia in ratsEuropean Journal of Pharmacology, 1999